IAXSX
Price
$9.50
Change
-$0.01 (-0.11%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

IAXSX vs RPTIX

Header iconIAXSX vs RPTIX Comparison
Open Charts IAXSX vs RPTIXBanner chart's image
VY® T. Rowe Price Divers Mid Cap Gr S
Price$9.50
Change-$0.01 (-0.11%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IAXSX vs RPTIX Comparison Chart
Loading...
VS
IAXSX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IAXSX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. IAXSX (1.11B). RPTIX pays higher dividends than IAXSX: RPTIX (0.18) vs IAXSX (0.00). IAXSX was incepted earlier than RPTIX: IAXSX (23 years) vs RPTIX (9 years). IAXSX is a more actively managed with annual turnover of: 45.00 vs. RPTIX (21.70). IAXSX has a lower initial minimum investment than RPTIX: IAXSX (0) vs RPTIX (500000). RPTIX annual gain was more profitable for investors over the last year : 14.81 vs. IAXSX (13.62). RPTIX return over 5 years is better than : 15.09 vs. IAXSX (-14.62).
IAXSXRPTIXIAXSX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD0.8489.1279%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.11B31.4B4%
Annual Yield % from dividends0.000.18-
Returns for 1 year13.6214.8192%
Returns for 3 years-30.79-13.57227%
Returns for 5 years-14.6215.09-97%
Returns for 10 years-13.82N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp